The present invention relates generally to management and storage, particularly management and storage of consumer products including medication and other regulated consumables.
Studies consistently show that patients have limited “health literacy.” In other words, patients, generally speaking, have limited understanding of the role they should play in their own health care. Limited patient health literacy results in limited use of preventive services, delayed diagnoses, lack of understanding of medical conditions, poor self-management skills, and failure to adhere to medical instructions. One specific aspect of patient health illiteracy is unintentional non-adherence to a medication regimen; studies have shown that half of patients misunderstand and demonstrate misuse of prescribed medications and that patients unnecessarily overcomplicate multi-drug regimens. Patients' misunderstanding of medication regimens, coupled with greater regimen complexity, results in less effective treatment, worse clinical outcomes, increased risk of hospitalization, poor physical and mental health, increased mortality risk, and greater healthcare costs. Some studies have shown these costs to range between $106 and $223 billion per year. What is needed is a comprehensive system enabling patients, physicians and pharmacists to more effectively communicate, and for patients to gain a greater understanding of their own health care and medication management.
The present disclosure is best understood with reference to the claims, the entire specification, and the drawings submitted herewith, which describe the systems, methods, and apparatuses of the present disclosure in greater detail. The summary is merely intended to convey aspects of illustrative embodiments.
The present disclosure relates to systems, methods, and apparatuses for the management, distribution, dispensing, and administration of consumer products, such as over-the-counter and prescription medications, through use of a product container labeling system and an optional integrated computer-based or online management system.
In certain aspects, the invention relates to a product container, e.g., medication container, comprising a hollow body, a child-resistant cap, and a specialized information label affixed to the hollow body. In certain embodiments, the hollow body may have a squared form that has a rectangular longitudinal shape and a rectangular or square cross-section, with one corner cut across. In other embodiments, the hollow body may have a circular or triangular cross-section.
In certain embodiments, the specialized information label may be configured such that, upon being affixed to the hollow body, part of the hollow body is visible, such that that contained product, e.g., medication, is easily visible though the label. In addition, in certain embodiments, the label may provide extra space for relevant information by providing fold-out panels.
In certain aspects, information printed on the specialized label may be correlated or linked with a computerized or online management system, such as an interactive website to keep, e.g., users, distributors, manufactures, patients, pharmacists, physicians and other interested parties organized and informed with respect to user's activities, e.g., all of a patient's prescribed and over-the-counter medications.
Additional objects, advantages and novel features of this invention will be set forth in part in the detailed description that follows, and in part will become apparent to those skilled in the art upon examination of the following description, or may be learned by practicing the invention.
In the accompanying drawings that form a part of the specification and are to be read in conjunction therewith, the present invention is illustrated by way of example and not limitation, with like reference numerals referring to like elements, wherein:
In the following detailed description, numerous specific details are set forth in order to provide a thorough understanding of embodiments of the disclosure. In other instances, well known structures, interfaces, and processes have not been shown in detail, as they are understood by those of skill in the art. It is intended that no part of this specification be construed to effect a disavowal of any part of the full scope of the disclosure.
The present invention relates to systems, methods, and apparatuses for the management, distribution, dispensing, and administration of consumer products, such as over-the-counter and prescription medications through use of a product container labeling system and an optional integrated computer-based or online management system. In certain embodiments, the invention relates to systems, methods, and apparatuses for use in connection with over-the-counter and prescription medications or other regulated consumer products. However, the invention is not so limited, and may be used in connection with any general consumer product, container and labeling system, etc., as may be understood by one of skill in the art. For instance, the specialized information label systems described herein may be used in connection with any suitable consumer product container, e.g., re-usable water or drink bottle, food container, drink container, etc. As will be recognized, the specialized information label systems of the invention may be used to provide required labeling, contents, ingredients, instructions, warnings, etc., for any consumer product, and can be configured to accommodate any consumer product packaging.
In certain aspects, the invention relates to a product container comprising a hollow body, a child-resistant cap, and a specialized information label affixed to the hollow body. In certain embodiments, the hollow body may have a squared form that has a rectangular longitudinal shape and a rectangular or square cross-section, optionally with one corner cut across. In other embodiments, the hollow body may have a rounded form, optionally with one corner cut across.
More particularly, the cap and the neck of the hollow body provide a unique child-resistant mechanism. In certain embodiments, the mechanism is tabbed, requiring a user to press the corners of the hollow body instead of the sides. This closure provides the spring mechanism required to reposition the tab after it has been reassembled onto the container.
In one embodiment, as illustrated in
With reference to
In certain embodiments, the hollow body may be round in form with one or more portions of the cross-sectional form optionally cut off at an angle to create one or more flat side(s). In other embodiments, the hollow body may be triangular in form with one or more corners of the cross-sectional form cut off at an angle to create one or more flat side(s). In yet other embodiments, the hollow body may be square or rectangular in form with one or more edges or corners cut off at an angle to create one or more flat side(s).
In one embodiment, multi-lead threads 142 of various sizes and configuration on the neck 140 of the hollow body 110, for which the bottle cap 120 is correspondingly grooved 144, ensure that the closure can be applied in only one position. Again, in certain embodiments, a locking mechanism may be including, such as tab 150 on hollow body 110 and corresponding locking tab 152 on cap 120, requiring a user to press the corners of the hollow body 110 to disengage locking tab 152. This closure provides the spring mechanism required to reposition the tab after it has been reassembled onto the container.
In certain embodiments, non-uniform spacing of the thread configuration may prevent the closure from being cross-threaded, preventing the threads from engaging in the wrong location or position. By way of example, as shown in
Generally, with reference to
In another aspect, a specialized information label is provided. In certain embodiments, the specialized information label of the invention may be secured to the hollow body described herein. The specialized label is generally designed to make it easier for a consumer to understand product information, contents, ingredients, administration instructions, warnings, etc. The specialized label may be configured in any suitable manner so as to accommodate a desired product container. For instance, the specialized information label systems described herein may be used in connection with any suitable consumer product container, e.g., re-usable water or drink bottle, food container, drink container, etc. As will be recognized, the specialized information label systems of the invention may be used to provide required labeling, contents, ingredients, instructions, warnings, etc., for any consumer product, and can be configured to accommodate any consumer product packaging.
More particularly, in certain embodiments, the specialized information label may be configured to accommodate a hollow body of a product container described herein. In certain embodiments, the specialized information label may include multiple panels sufficient in number to align with surfaces of the hollow body. In certain embodiments, the label may wrap around only a portion of the hollow body (plus the Flat(s)), leaving the remaining side or portion unlabeled, to thereby leave a side or portion of the hollow body available for viewing of the contents of the hollow body (e.g., contents, pills or liquid remaining in the container).
As depicted in
As shown in
In certain embodiments, the MedChart may have two or more vertical columns or multiple divided areas (e.g., horizontal divided areas, diagonal, etc.), separated into multiple rows or subareas. In the first column or divided area, an icon or pictorial representation may be listed in each corresponding row or subarea for a medication administration timeframe, such as morning, noon, evening, bed time, meal time (breakfast, lunch, dinner, snack time), etc. The second column or divided area may call out (e.g., through pictorial representation), in the corresponding row or subarea, the amount of medication to be taken during that particular time frame.
A fourth outer panel 510d may, e.g., include the name of the medication in large, bold type, as well as measurement markers for liquid medications. This feature allows an individual to immediately determine the contents of the bottle. The fourth outer panel, in certain embodiments, may be configured to be aligned with the Flat 130 of the hollow body upon securing to the pharmaceutical container.
An expandable feature of the label 510e, configured to fold out from the hollow body upon securing to a container, e.g., a pharmaceutical container (see, e.g.,
With reference to
In an alternative embodiment, e.g., as illustrated in
A fourth outer panel 610d may include, e.g., the name of the medication in large, bold type, as well as measurement markers for liquid medications. This feature allows an individual to immediately determine the contents of the bottle. The fourth outer panel, in certain embodiments, may be configured to be aligned with the Flat 130 of the hollow body upon securing to the pharmaceutical container.
An expandable feature of the label 610e, configured to fold out along 610e-3 from the hollow body upon securing to the pharmaceutical container (see, e.g.,
An optional feature may be included which allows for a clear view window, 610h. In certain embodiments, panel 610h may be configured with a die-cut window 610h-1 that may be removed prior to, upon application, or following application to a pharmaceutical container, to thereby allow visual access to the container.
In another embodiment, e.g., as illustrated in
An expandable feature of the label 710d, configured to fold along fold-lines 710e to provide for the expandable feature, may include one or more inner panels 710d-1, 710d-2 that can include useful information, e.g., for user administration, usage and warnings, etc. Upon folding, outer panel 710b releasably secures to outer panel 710a to conceal inner panels 710d-1 and 710d-2 within expandable feature 710d. Upon folding out of the label, inner panels 710d-1 and 710d-2 may then be viewed.
Additional views of the label shown in
The containers described herein provide a variety of benefits. Without intending to be limited, in certain embodiments, storing the bottles is simple: all bottles can be organized with the “front” facing outwards, so that relevant information is easily legible. This is convenient both for pharmacists and consumers. The configuration and sizing allows for more information to be conveyed on the specialized label. Further, the configuration and shape may improve ease of use. For example, child-resistant caps on medication bottles are usually troublesome to push and twist even for the most skilled set of hands. The unique shape of the container, combined with the novel form of child resistant cap, provides an additional point of leverage making the container easy to grip and open. In certain embodiments, the Flat may provide a convenient surface on the closure for a thumb or finger while pressing inward to release the child-resistant tab from the latch on the bottle.
In yet another aspect, a specialized label incorporating a MedChart may link users (e.g., pharmacists, prescribers, patients, etc.) to an interactive medication management system where users can get assistance in monitoring medications, dosing regimens, as well as accurately track current and past medications. In certain embodiments, the interactive medication management system may be a stand-alone computer system, a networked computer system, an on-line computer system, a website, etc.
In certain embodiments, the MedChart of the specialized label may be replicated on and linked to the interactive medication management system. By way of example, the specialized label may include information which directs patients to a website, where patients may view information concerning medication related to the MedChart, input additional medication information, organize and keep track of their medications, as well as share their information with other authorized users, including authorized family members, authorized prescribers, authorized pharmacists, etc. Further, the website may connect the patient with his or her prescribers, dispensers, and other health professionals to improve communication across these lines of health care, assuring proper understanding around medication regimens and promoting adherence.
In one embodiment of the invention, the interactive medication management system may include one or more of the following types of interactive online content:
a “home” page providing an overview of the medication management system (see
a “tour” page providing a more comprehensive explanation of how the interactive management system works (not shown);
an encrypted registration page and portal for consumers to enter their 1) personal health history, 2) daily/weekly/monthly medication regimen, and 3) provider profiles (pharmacy, physicians). “Sign up” may, in some embodiments, be driven by the pharmacy or the physician (see
a resources page to direct patients to useful web links and local community resources (not shown); a “medical organizer” page which pulls together all pertinent information and displays any necessary alerts, such as “Your medication X has been recalled,” or “You have a prescription ready at the pharmacy.” This page may also provide options for adding and organizing medications (both over-the-counter and prescription) and user preferences, such as alert notifications (see
a “medical reminder” page, which provides adherence support to consumers by providing options for consumers to receive electronic reminders to take medicine, order a refill, or go to a medical appointment via social networking sites (such as Facebook, MySpace, Twitter, etc.) or via email, SMS, text, etc. (see
a “medical share” page, which provides an option to share personal medication information and communicate with pharmacists, health care providers, caregivers, and/or family members (see
By way of non-limiting example, an illustrative map of online content of an interactive medication management system is shown in
The interactive medication management system may also provide an option for an on-line viewable and/or computer-printable pictorial management service. By way of example, the on-line viewable and/or computer-printable pictorial management service may provide an option to view and/or print dosing and/or appointment calendars, e.g., pocket calendars, desk calendars, etc., including daily, weekly, monthly, etc. dosing instructions (e.g., MedChart information), refill reminders, appointment reminders, etc.
The interactive medication management system provides numerous benefits for users, such as reducing the need for in-person or telephone interactions with medical providers, assisting the patient in adhering to a schedule, organizing medications, providing reminders, sharing information, and tracking side effects. The interactive system can also consolidate all of the patient's medications, whether over-the-counter or prescribed. It may generate a complete MedChart which gives a visual indicator of medication schedules and may be linked to the MedChart shown on each label. The interactive system may also provide for comprehensive information sharing; by patient invitation, the system may allow healthcare providers access to medical records and to be notified when the patient fills or refills a medication. It may also allow a patient to share information with family members or friends. The system may further provide links for medication information, such as medical references, the FDA website, or insurance education websites. It may also include a forum, where users can discuss health issues or consult with physicians or pharmacists about concerns.
The interactive system also provides benefits for physicians. The website provides a medication reconciliation tool, which serves as a master list of all medications taken by each patient, including over-the-counter medications and medications prescribed by other providers. This may prevent harmful interactions not caught at the pharmacy. The system also provides adherence follow-up information, such as a confirmation of whether the patient filled or refilled medications at the right times. It may assist in early intervention, by increasing communication and counseling with patients through a chat room or emailed questions.
The system further provides benefits for pharmacists and dispensers. It may serve as the “Medication Therapy Management” component under Medicare Part D, which allows pharmacies to include counseling over medications as part of the dispensing fee. The system may direct patient communication; if a patient is late on refills or if important updates are issues for a medication precaution, these issues are easy to address. The system may serve as a bridging function for medical and pharmacy technology. Further, the system may encourage efficiency, by allowing for easier and faster refill orders, and ensuring that these occur at the proper time by the ability to notify patients that they need to call in a refill, or even allow for an ‘opt out’ function.
What has been described and illustrated herein is a preferred embodiment of the invention along with some of its variations. The terms, descriptions and figures used herein are set forth by way of illustration only and are not meant as limitations. Those skilled in the art will recognize that many variations are possible within the spirit and scope of the invention, which is intended to be defined by the following claims, in which all terms are meant in their broadest reasonable sense unless otherwise indicated therein.
This application is a continuation of U.S. application Ser. No. 16/350,213, filed Oct. 17, 2018, which is a continuation of U.S. application Ser. No. 15/600,498, filed May 19, 2017, which is a divisional application of U.S. application Ser. No. 14/272,000, filed May 7, 2014, which is a continuation-in-part of U.S. application Ser. No. 13/389,991, filed Sep. 11, 2013, which is a national stage under 35 U.S.C. § 371 of International Application No. PCT/US2011/63900, filed Dec. 8, 2011, wherein International Application No. PCT/US2011/63900 claims the benefit of U.S. Provisional Application No. 61/422,008, filed Dec. 10, 2010, and is a continuation-in-part application of International Application No. PCT/US2010/045388, filed Aug. 12, 2010, which claims the benefit of U.S. Provisional Application No. 61/233,426, filed Aug. 12, 2009, and U.S. Provisional Application No. 61/233,781, filed Aug. 13, 2009, the contents of which are herein incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
532093 | Pollard | Jan 1895 | A |
2007685 | Lyle | Jul 1935 | A |
4028824 | Miller | Jun 1977 | A |
4128954 | White | Dec 1978 | A |
4312523 | Haines | Jan 1982 | A |
4318477 | Kerpe | Mar 1982 | A |
RE30958 | White | Jun 1982 | E |
4727667 | Ingle | Mar 1988 | A |
4730849 | Siegel | Mar 1988 | A |
4732411 | Siegel | Mar 1988 | A |
4766542 | Pilarczyk | Aug 1988 | A |
4799712 | Biava et al. | Jan 1989 | A |
4883180 | Humphrey et al. | Nov 1989 | A |
5031937 | Nellhaus | Jul 1991 | A |
5102169 | Mayfield | Apr 1992 | A |
5207746 | Jones | May 1993 | A |
5261702 | Mayfield | Nov 1993 | A |
5342093 | Weernink | Aug 1994 | A |
D350691 | Simion | Sep 1994 | S |
5495944 | Lerner | Mar 1996 | A |
5642906 | Foote et al. | Jul 1997 | A |
5687863 | Kusz | Nov 1997 | A |
5727819 | Grooskopf et al. | Mar 1998 | A |
5752723 | Robertson | May 1998 | A |
5779072 | Krebs | Jul 1998 | A |
5829789 | Treleaven et al. | Nov 1998 | A |
5958536 | Gelsinger et al. | Sep 1999 | A |
5991731 | Colon et al. | Nov 1999 | A |
6014631 | Teagarden et al. | Jan 2000 | A |
6189936 | Erber et al. | Feb 2001 | B1 |
6260761 | Peoples, Jr. | Jul 2001 | B1 |
6263330 | Bessette | Jul 2001 | B1 |
6272777 | Swenson | Aug 2001 | B1 |
6305377 | Portwood et al. | Oct 2001 | B1 |
6352608 | Garden | Mar 2002 | B1 |
6357798 | Chess | Mar 2002 | B1 |
6367640 | Julian | Apr 2002 | B1 |
6402872 | Key | Jun 2002 | B1 |
6432500 | Jones et al. | Aug 2002 | B1 |
6491995 | Schreiner | Dec 2002 | B1 |
6613410 | Sellars | Sep 2003 | B1 |
6637775 | Bernier et al. | Oct 2003 | B1 |
6671563 | Engelson et al. | Dec 2003 | B1 |
6680098 | Aakermann | Jan 2004 | B1 |
6757898 | Ilsen et al. | Jun 2004 | B1 |
6770345 | Sellars | Aug 2004 | B2 |
6802810 | Ciarniello et al. | Oct 2004 | B2 |
6860513 | Kaufman | Mar 2005 | B2 |
6953207 | Raming | Oct 2005 | B2 |
6967046 | Bollinger et al. | Nov 2005 | B2 |
6988075 | Hacker | Jan 2006 | B1 |
6994249 | Peterka et al. | Feb 2006 | B2 |
7039628 | Logan, Jr. | May 2006 | B2 |
7076437 | Levy | Jul 2006 | B1 |
7195689 | Adams et al. | Mar 2007 | B2 |
D540179 | Adler et al. | Apr 2007 | S |
D540690 | Adler et al. | Apr 2007 | S |
D542661 | Adler et al. | May 2007 | S |
7225052 | Foote et al. | May 2007 | B2 |
D544789 | Kaufman | Jun 2007 | S |
7225937 | Schroeder | Jun 2007 | B2 |
7286997 | Spector et al. | Oct 2007 | B2 |
7311205 | Adler et al. | Dec 2007 | B2 |
D562687 | Kaufman | Feb 2008 | S |
7395214 | Shillingburg | Jul 2008 | B2 |
7398999 | Kaufman | Jul 2008 | B2 |
D574717 | Adler et al. | Aug 2008 | S |
7413082 | Adler et al. | Aug 2008 | B2 |
7424437 | Maus et al. | Sep 2008 | B2 |
7426475 | Tangellapally et al. | Sep 2008 | B1 |
D581275 | Adler et al. | Nov 2008 | S |
D583242 | Adler et al. | Dec 2008 | S |
7458177 | Sandel et al. | Dec 2008 | B2 |
7464043 | Dussia | Dec 2008 | B1 |
D594336 | Adler | Jun 2009 | S |
7740411 | Kaufman | Jun 2010 | B2 |
7926850 | Muncy et al. | Apr 2011 | B1 |
7926851 | Kaufman | Apr 2011 | B2 |
8020702 | Strub et al. | Sep 2011 | B2 |
8025314 | Adler | Sep 2011 | B2 |
8037628 | Kaufman | Oct 2011 | B2 |
9643771 | Adler et al. | May 2017 | B2 |
20010001144 | Kapp | May 2001 | A1 |
20020184051 | Yu et al. | Dec 2002 | A1 |
20030047937 | Chaduc et al. | Mar 2003 | A1 |
20030111837 | Foote et al. | Jun 2003 | A1 |
20030112466 | Leonardi | Jun 2003 | A1 |
20030177033 | Park et al. | Sep 2003 | A1 |
20030189732 | Bean et al. | Oct 2003 | A1 |
20030193181 | Hung | Oct 2003 | A1 |
20030193185 | Valley et al. | Oct 2003 | A1 |
20030205897 | Kaufman | Nov 2003 | A1 |
20030214129 | Adler | Nov 2003 | A1 |
20030225595 | Helmus et al. | Dec 2003 | A1 |
20040009347 | Bolnick et al. | Jan 2004 | A1 |
20040075272 | Kaufman | Apr 2004 | A1 |
20040153339 | Hetzel | Aug 2004 | A1 |
20040169000 | Ramsey | Sep 2004 | A1 |
20040181982 | Sandel et al. | Sep 2004 | A1 |
20040193454 | Foote et al. | Sep 2004 | A1 |
20040199404 | Ripperger et al. | Oct 2004 | A1 |
20040243434 | Peterka et al. | Dec 2004 | A1 |
20040247812 | Milliorn et al. | Dec 2004 | A1 |
20040251165 | Girzaitis | Dec 2004 | A1 |
20050019518 | Bollinger et al. | Jan 2005 | A1 |
20050038558 | Keene | Feb 2005 | A1 |
20050040642 | Jiang | Feb 2005 | A1 |
20050056203 | Giewercer | Mar 2005 | A1 |
20050140135 | Miller et al. | Jun 2005 | A1 |
20050171815 | Vanderveen | Aug 2005 | A1 |
20050268505 | Sandel et al. | Dec 2005 | A1 |
20060029766 | Bolnick et al. | Feb 2006 | A1 |
20060078701 | Glasier | Apr 2006 | A1 |
20060144919 | Tong | Jul 2006 | A1 |
20060163103 | Adler et al. | Jul 2006 | A1 |
20060163110 | Adler et al. | Jul 2006 | A1 |
20060163869 | Adler et al. | Jul 2006 | A1 |
20060197336 | Londino | Sep 2006 | A1 |
20070029788 | Adler | Feb 2007 | A1 |
20070034103 | Kaufman | Feb 2007 | A1 |
20070095850 | Meyer | May 2007 | A1 |
20070164096 | Banfield et al. | Jul 2007 | A1 |
20070172429 | Gao et al. | Jul 2007 | A1 |
20070204497 | de la Huerga | Sep 2007 | A1 |
20070214018 | Claud, III | Sep 2007 | A1 |
20070250341 | Howe et al. | Oct 2007 | A1 |
20070250346 | Luciano, Jr. et al. | Oct 2007 | A1 |
20070252378 | Chambers | Nov 2007 | A1 |
20070267430 | Luciano, Jr. et al. | Nov 2007 | A1 |
20070270998 | Luciano, Jr. et al. | Nov 2007 | A1 |
20080015897 | Moradi et al. | Jan 2008 | A1 |
20080017602 | Adler et al. | Jan 2008 | A1 |
20080035659 | Ricker et al. | Feb 2008 | A1 |
20080042423 | Roberts et al. | Feb 2008 | A1 |
20080046294 | Fiedotin et al. | Feb 2008 | A1 |
20080052129 | Beraja et al. | Feb 2008 | A1 |
20080056556 | Eller et al. | Mar 2008 | A1 |
20080071572 | Ahmed | Mar 2008 | A1 |
20080086337 | Soon-Shiong | Apr 2008 | A1 |
20080086339 | Jung et al. | Apr 2008 | A1 |
20080091468 | Heidenreich et al. | Apr 2008 | A1 |
20080097787 | Palazzolo et al. | Apr 2008 | A1 |
20080097918 | Dicks et al. | Apr 2008 | A1 |
20080099367 | Niemiec et al. | May 2008 | A1 |
20080103827 | Niemiec et al. | May 2008 | A1 |
20080126135 | Woo | May 2008 | A1 |
20080140449 | Hayes | Jun 2008 | A1 |
20080150275 | Raistrick | Jun 2008 | A1 |
20080154643 | Leon | Jun 2008 | A1 |
20080162181 | Ben-Haim et al. | Jul 2008 | A1 |
20080197619 | Tussey | Aug 2008 | A1 |
20080201173 | Takehara et al. | Aug 2008 | A1 |
20080215374 | Craft | Sep 2008 | A1 |
20080228519 | Leon | Sep 2008 | A1 |
20080228524 | Brown | Sep 2008 | A1 |
20080235050 | Hallberg | Sep 2008 | A1 |
20080235059 | Gonzalvo | Sep 2008 | A1 |
20080257777 | Miceli et al. | Oct 2008 | A1 |
20080262868 | Malolepszy | Oct 2008 | A1 |
20080262930 | Miceli et al. | Oct 2008 | A1 |
20080276008 | Leon | Nov 2008 | A1 |
20080287746 | Reisman | Nov 2008 | A1 |
20080288287 | Stanners et al. | Nov 2008 | A1 |
20080294462 | Nuhaan et al. | Nov 2008 | A1 |
20080301982 | Kaufman | Dec 2008 | A1 |
20080303264 | Kaufman | Dec 2008 | A1 |
20080312957 | Luciano, Jr. et al. | Dec 2008 | A1 |
20080319784 | Cordero | Dec 2008 | A1 |
20090012373 | Raij et al. | Jan 2009 | A1 |
20090012820 | Bishop et al. | Jan 2009 | A1 |
20090019552 | McLaughlin et al. | Jan 2009 | A1 |
20090024416 | McLaughlin et al. | Jan 2009 | A1 |
20090024417 | Marks et al. | Jan 2009 | A1 |
20090030719 | Nadas et al. | Jan 2009 | A1 |
20090030725 | Palazzolo et al. | Jan 2009 | A1 |
20090140513 | Priebe et al. | Jun 2009 | A1 |
20130341329 | Adler et al. | Dec 2013 | A1 |
20140195042 | Adler | Jul 2014 | A1 |
20140246349 | Adler et al. | Sep 2014 | A1 |
20140257843 | Adler et al. | Sep 2014 | A1 |
20150352009 | Miller | Dec 2015 | A1 |
Number | Date | Country |
---|---|---|
2 527 673 | Dec 2004 | CA |
1911739 | Feb 2007 | CN |
1911740 | Feb 2007 | CN |
102005056037 | Jun 2007 | DE |
0 441 023 | Aug 1991 | EP |
1 882 635 | Jan 2008 | EP |
2 006 713 | May 1979 | GB |
2 277 075 | Oct 1994 | GB |
2 380 467 | Apr 2003 | GB |
10-297640 | Nov 1998 | JP |
2003-108002 | Apr 2003 | JP |
2006-68175 | Mar 2006 | JP |
WO 0168454 | Sep 2001 | WO |
WO 0229664 | Apr 2002 | WO |
WO 2002094579 | Nov 2002 | WO |
WO 03098275 | Nov 2003 | WO |
WO 2004084159 | Sep 2004 | WO |
WO 2004109626 | Dec 2004 | WO |
WO 2005020195 | Mar 2005 | WO |
WO 2006049937 | May 2006 | WO |
WO 2006080945 | Aug 2006 | WO |
WO 2007074394 | Jul 2007 | WO |
WO 2007084159 | Jul 2007 | WO |
WO 2007127359 | Nov 2007 | WO |
WO 2011019967 | Feb 2011 | WO |
WO 2012078840 | Apr 2012 | WO |
Entry |
---|
Alastair J.J. Wood, MD, “Simplifying Medication Scheduling: Can We Confuse Patients Less?,” 38 page presentation, retrieved on Jul. 19, 2014, from: www.iom.edu/˜/media/Files/Activity%20Files/PublicHealth/HealthLiteracy/wood.pdf. |
Bailey et al., “A Universal Medication Schedule to Promote Patient Understanding and Use,” 17 pages, retrieved on Dec. 16, 2013, from: www.bumc.bu.edu/healthliteracyconverence/files/2009/10/bailey-2009_1.pdf. |
Canadian Examiner's Report dated Apr. 4, 2017, issued in CA 2,769,851. |
Canadian Examiner's Report dated Feb. 24, 2016, issued in CA 2,769,851. |
“ConXus Workplace Wellnes Platform PDHI,” 1 page, retrieved on Oct. 26, 2012, from www.pdhi.com. |
Gross, “Microsoft launches online e-health service,” 3 pages, retrieved on Feb. 1, 2009, from www.computerworld.com. |
International Search Report, International Application No. PCT/US2010/045388 (published as WO 2011/019967) (dated Jan. 18, 2011). |
International Search Report dated Apr. 19, 2012, in International Patent Application No. PCT/US2011/063900. |
Kusserow, Medication Regimens: Causes of Noncompliance, Office of Inspector General—0E1-04-89-891 21. 38 pgs. (1990) <https://oig.hhs.gov/oei/reports/oei-04-89-89121.pdf>. |
“MyMedicalRecords.com User Guide,” 15 pages, dated May 31, 2007. |
“NoMoreClipboard.com—Your Secure Personal Health Record,” 5 pages, retrieved on Feb. 1, 2009, from www.nomoreclipboard.com. |
“PersonalMD.Com—Your Lifeline Online,” 9 pages, retrieved on Feb. 1, 2009, from www.personalmd.com. |
Vascellaro et al., “Google, IBM Promote Online Health Records,” The Wall Street Journal, Feb. 5, 2009 (1 page). |
Number | Date | Country | |
---|---|---|---|
20190122754 A1 | Apr 2019 | US |
Number | Date | Country | |
---|---|---|---|
61422008 | Dec 2010 | US | |
61233426 | Aug 2009 | US | |
61233781 | Aug 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14272000 | May 2014 | US |
Child | 15600498 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16350213 | Oct 2018 | US |
Child | 16230682 | US | |
Parent | 15600498 | May 2017 | US |
Child | 16350213 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13389991 | US | |
Child | 14272000 | US | |
Parent | PCT/US2010/045388 | Aug 2010 | US |
Child | 13389991 | US |